Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Getting Personal: Better Diagnosis, Better Treatment

Posted on September 8th, 2017 by in Pharma R&D

Figures released by the U.S. National Cancer Institute (NCI) in 2017 indicate that the burden of cancer is on the rise, with the number of diagnoses rising by 50% over the next 13 years. Even more troubling is the predicted mortality rate for cancer, Continue reading “Getting Personal: Better Diagnosis, Better Treatment” »

Making Precision Medicine a Reality

Posted on April 24th, 2017 by in Chemistry

Precision medicine is no longer just a promising new development discussed only by medical professionals and industry insiders at conferences and in journals. In early 2015, former U.S. President Barack Obama announced the $215 million Precision Medicine Initiative Continue reading “Making Precision Medicine a Reality” »

The Costs of Irreproducible Biomedical Research

Posted on November 28th, 2016 by in Pharma R&D

money-case-163495_640

Issues with reproducibility plague basic biomedical research. In a June 2015 study published in PLoS Biology, the authors suggested that U.S. researchers spend $28 billion a year on research that is irreproducible. Continue reading “The Costs of Irreproducible Biomedical Research” »